HC Wainwright & Co. Reiterates Buy on NovaBridge Biosciences, Maintains $9 Price Target
HC Wainwright & Co. analyst Andres Y. Maldonado reiterates NovaBridge Biosciences (NASDAQ:NBP) with a Buy and maintains $9 price target.
Read original at benzinga